DHR

Danaher Corporation Common Stock (DHR)

About Danaher Corporation Common Stock (DHR)

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Details

Daily high
$215.54
Daily low
$214.28
Price at open
$214.85
52 Week High
$242.80
52 Week Low
$160.93
Market cap
151.7B
Dividend yield
0.67%
Volume
163,673
Avg. volume
3.6M
P/E ratio
38.32

Danaher Corporation Common Stock News

Details

Daily high
$215.54
Daily low
$214.28
Price at open
$214.85
52 Week High
$242.80
52 Week Low
$160.93
Market cap
151.7B
Dividend yield
0.67%
Volume
163,673
Avg. volume
3.6M
P/E ratio
38.32